Abuse of Prescription and Over-the-Counter Medications

References

1. ↵
   DuPont RL. Prescription stimulant abuse. Psychiatr Ann 2005; 35: 93–7.

   OpenUrl
2. ↵
   Collins GB, McAllister MS. Combating abuse and diversion of prescription opiate medications. Psychiatr Ann 2006; 36: 410–6.

   OpenUrl
3. ↵
   Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: national findings. Rockville (MD): Office of Applied Studies, NSDUH Series H-30, DHHS Publication no. 2006;SMA 06–4194.
4. ↵
   Center for Disease Control and Prevention. Unintentional deaths from drug poisoning by urbanization of area: New Mexico, 1994–2003. MJWR 2005; 54: 870–3.

   OpenUrl
5. ↵
   National Survey on Drug Use and Health. Non-medical use of prescription pain relievers. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2004.
6. ↵
   Lessenger JE, Lessenger LH, Lessenger EW. An outcome analysis of Drug Court in Tulare County, California. Visalia (CA): Tulare County Superior Court; 2000.
7. ↵
   National Survey on Drug Use and Health. Characteristics of primary prescription and OTC treatment admissions: 2002. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2004.
8. ↵
   Drug Abuse Warning Network. Emergency department visits involving non-medical use of selected pharmaceuticals. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2006.
9. ↵
   Miller WR, Baca C, Compton WM, et al. Addressing substance abuse in health care settings. Alcohol Clin Exp Res 2006; 30: 292–302.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Goodman FDC, Glassman P. Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone. Am J Health Syst Pharm 2005; 62: 2604–8.

    OpenUrlFREE Full Text
11. ↵
    National Household Survey on Drug Abuse. Non-medical use of prescription-type drugs among youths and young adults. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2003.
12. ↵
    Drug Abuse Warning Network. Emergency department visits involving ADHD stimulant medications. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2006.
13. ↵
    Miller NS. Physicians and the controlled substance laws for opiate prescription medications. Psychiatr Ann 2006; 36: 422–9.

    OpenUrl
14. ↵
    Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 2002; 18: S61–9.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    London M. Prevention of substance abuse. Curr Opin Psychiatry 2001; 14: 207–11.

    OpenUrl
16. ↵
    Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage 2004; 28: 176–88.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    National Institute on Drug Abuse. Prescription drug abuse chart. Washington, DC: National Institute on Drug Abuse; 2006.
18. ↵
    The National Center on Addiction and Substance Abuse at Columbia University. You’ve got drugs: prescription drug pushers on the internet: 2006 update. New York: The National Center on Addiction and Substance Abuse at Columbia University; 2006.
19. ↵
    Carter LP, Richards BD, Mintzer MZ, Griffiths RR. Relative abuse liability of GHB in humans: a comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology 2006; 31: 2537–51.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Trescott AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006; 9: 1–40.

    OpenUrlPubMed
21. ↵
    Bewley T, Ghodse AH. Unacceptable face of private practice: prescription of controlled drugs to addicts. BMJ 1983; 286: 1876–7.

    OpenUrlAbstract/FREE Full Text
22. ↵
    Longo L, Johnson B. Addiction: part I. Benzodiazepines: side effects, abuse risk and alternatives. Am Fam Physician 2000; 61: 2121–8.

    OpenUrlPubMedWeb of Science
23. ↵
    Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM. Carisoprodol (Soma): abuse potential and physician unawareness. J Addict Dis 1999; 18: 51–6.

    OpenUrlCrossRefPubMed
24. ↵
    Fisher DG, Malow R, Rosenberg R, Reynolds GL, Farrell N, Jaffe A. Recreational Viagra use and sexual risk among drug abusing men. Am J Infect Dis 2006; 2: 107–14.

    OpenUrlPubMed
25. ↵
    Musacchio NS, Hartrich M, Garofalo E. Erectile dysfunction and Viagra use: what's up with college-age males? J Adolesc Health 2006; 39: 452–4.

    OpenUrlPubMed
26. ↵
    McCambridge J, Mitcheson L, Hunt N, Winstock A. The rise of Viagra among British illicit drugs uses: 5-year survey data. Drug Alcohol Rev 2006; 25: 111–3.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    Fernandez MI, Perrino T, Collazo JB, et al. Surging new territory: club-drug use and risky sex among Hispanic men who have sex with men recruited on the Internet. J Urban Health 2005; 82(1 Suppl 1): i79–88. Epub 2005 Feb 28.

    OpenUrl
28. ↵
    Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 2006; 82: 131–4.

    OpenUrlAbstract/FREE Full Text
29. ↵
    Paul JP, Pollack L, Osmond D, Catania JA. Viagra (sildenafil) use in a population-based sample of U.S. men who have sex with men. Sex Transm Dis 2005; 32: 531–3.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    Purcell Dw, Wolitski RJ, Hoff CC, Parsons JT, Woods WJ, Halkitis PN. Predictors of the use of Viagra, testosterone, and antidepressants among HIV-seropositive gay and bisexual men. AIDS 2005; 19(suppl 1): S57–66.

    OpenUrl
31. ↵
    Copeland J, Dillon P, Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addict Behav 2006; 31: 367–70.

    OpenUrlCrossRefPubMed
32. ↵
    Abbot FV, Fraser MI. Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci 1998; 23: 13–34.

    OpenUrlPubMedWeb of Science
33. ↵
    Kanayama G, Gruber AJ, Pope HG, Borowieckii JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an under-recognized substance abuse problem? Psychother Psychosom 2001; 70: 137–40.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    National Institute on Drug Abuse. Hallucinogens and dissociative drugs. Washington, DC: National Institute on Drug Abuse; 2006.
35. ↵
    Schwartz RH. Adolescent abuse of dextromethorphan. Clin Pediatr (Phila) 2005; 44: 565–8.

    OpenUrlAbstract/FREE Full Text
36. ↵
    Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addict Biol 2005; 10: 325–7.

    OpenUrlCrossRefPubMedWeb of Science
37. ↵
    Desai S, Aldea D, Daneels E, Soliman M, Braksmajer AS, Kopes-Kerr CP. Chronic addiction to dextromethorphan cough syrup: a case report. J Am Board Fam Med 2006; 19: 320–3.

    OpenUrlAbstract/FREE Full Text
38. ↵
    Baker SD, Borys DJ. A possible trend suggesting increased abuse from Coricidin exposures reported to the Texas Poison Network: comprising 1998 to 1999. Vet Hum Toxicol 2002; 44: 169–71.

    OpenUrlPubMedWeb of Science
39. ↵
    Austin H, Monasterio E. Acute psychosis following ingestion of “Rapture.” Australas Psychiatry 2004; 12: 406–8.

    OpenUrlAbstract/FREE Full Text
40. ↵
    Halpert AG, Olmstead MC, Beninger RJ. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci Biobehav Rev 2002; 26: 61–7.

    OpenUrlCrossRefPubMedWeb of Science
41. ↵
    Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry 2005; 66: 31–41.

    OpenUrlPubMedWeb of Science
42. ↵
    Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine: a survey of 68 clinical and 55 death cases. Forensic Sci Int 2006; 161: 189–97.

    OpenUrlCrossRefPubMedWeb of Science
43. ↵
    Nigro SA. Toxic psychosis due to diphenhydramine hydrochloride. JAMA 1968; 203: 301–2.

    OpenUrlCrossRefPubMed
44. ↵
    Kockler DR, McCarthy MW, Lawson CL. Seizure activity and unresponsiveness after Hydrocut ingestion. Pharmacotherapy 2001; 21: 647–51.

    OpenUrlCrossRefPubMedWeb of Science
45. Bassett KE, Schunk JE, Crouch BI. Cyclizine abuse by teenagers in Utah. Am J Emerg Med 1996; 14: 472–4.

    OpenUrlCrossRefPubMedWeb of Science
46. ↵
    Hall AH, Kulig KW, Rumack BH. Intravenous epinephrine abuse. Am J Emerg Med 1987; 5: 64–5.

    OpenUrlPubMed